List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 11752 studies with search of: Open Studies | "Neoplasms"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
Conditions: Breast Cancer;   Colorectal Cancer;   Esophageal Cancer;   Head and Neck Cancer;   Lung Cancer
Interventions: Other: 18F-fluoromisonidazole;   Other: fluorescence angiography;   Other: laboratory biomarker analysis;   Procedure: infrared thermography;   Procedure: magnetic resonance imaging;   Procedure: therapeutic conventional surgery;   Radiation: [18F]-ML-10;   Radiation: fludeoxyglucose F 18;   Radiation: rubidium Rb-82
2 Recruiting Temsirolimus and Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial Cancer, Liver Cancer, Islet Cell Cancer, or Carcinoid Tumor
Conditions: Endometrial Cancer;   Gastrointestinal Carcinoid Tumor;   Islet Cell Tumor;   Liver Cancer;   Lung Cancer;   Ovarian Cancer
Interventions: Biological: bevacizumab;   Drug: temsirolimus;   Other: laboratory biomarker analysis
3 Recruiting Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Conditions: Neoplasms;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Primary Peritoneal Neoplasm
Interventions: Biological: KHK2866;   Drug: Gemcitabine and Carboplatin;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin
4 Unknown † Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Conditions: Breast Cancer;   Colorectal Cancer;   Gastric Cancer;   Liver Cancer;   Melanoma (Skin);   Metastatic Cancer;   Ovarian Cancer;   Pancreatic Cancer
Interventions: Drug: cyclophosphamide;   Drug: poly ICLC;   Procedure: hepatic artery embolization;   Radiation: 3-dimensional conformal radiation therapy
5 Recruiting A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Conditions: CD27 Expressing B-cell Malignancies;   CD27 Expressing Solid Tumors;   Chronic Lymphocytic Leukemia;   Burkett's Lymphoma;   Mantle Cell Lymphoma;   Primary Lymphoma of the Central Nervous System;   Marginal Zone B Cell Lymphoma;   Solid Tumor;   Metastatic Melanoma;   Renal (Clear) Cell Carcinoma;   Hormone-refractory Prostate Adenocarcinoma;   Ovarian Cancer;   Colorectal Adenocarcinoma;   Non-small Cell Lung Cancer
Intervention: Drug: CDX-1127
6 Not yet recruiting Veliparib and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer
Conditions: Breast Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: veliparib;   Other: laboratory biomarker analysis;   Other: pharmacological study
7 Recruiting A Phase II Study of Lymphodepletion Followed by Autologous Tumor-Infiltrating Lymphocytes and High-Dose Adesleukin for Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Oropharyngeal Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer
Interventions: Drug: Fluderabine;   Drug: Cycolphosphamide;   Biological: Young TIL;   Biological: Aldesleukin
8 Unknown † ABT-888 in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Conditions: brca1 Mutation Carrier;   brca2 Mutation Carrier;   Breast Cancer;   Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Pancreatic Cancer;   Peritoneal Cavity Cancer;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: veliparib;   Other: laboratory biomarker analysis;   Other: pharmacological study
9 Recruiting Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Liver Cancer;   Pancreatic Cancer;   Periampullary Adenocarcinoma;   Small Intestine Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: gemcitabine hydrochloride;   Drug: oxaliplatin;   Other: laboratory biomarker analysis
10 Unknown † Cognitive and Behavioral Therapy or Standard Care in Patients With Advanced Gastrointestinal Cancer or Lung Cancer
Conditions: Anxiety Disorder;   Colorectal Cancer;   Depression;   Esophageal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Lung Cancer;   Pancreatic Cancer;   Psychosocial Effects of Cancer and Its Treatment
Interventions: Other: counseling intervention;   Other: educational intervention;   Other: questionnaire administration;   Procedure: meditation therapy;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment;   Procedure: standard follow-up care
11 Recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Conditions: Neuroendocrine Neoplasms;   Thyroid Neoplasms;   Parathyroid Neoplasms;   Adrenal Neoplasm;   Neuroblastoma
Intervention:
12 Recruiting Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Cervical Cancer;   Endometrial Cancer;   Esophageal Cancer;   Fallopian Tube Cancer;   Gastric Cancer;   Ovarian Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: informational intervention;   Procedure: assessment of therapy complications;   Procedure: psychosocial assessment and care
13 Unknown † Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Metastatic Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma;   Small Intestine Cancer
Interventions: Other: immunologic technique;   Other: pharmacological study;   Radiation: iodine I 131 monoclonal antibody 3F8
14 Unknown † Ixabepilone and Liposomal Doxorubicin in Treating Women With Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer or Metastatic Breast Cancer
Conditions: Breast Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: ixabepilone;   Drug: pegylated liposomal doxorubicin hydrochloride
15 Recruiting Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
Conditions: Gastrointestinal Neoplasms;   Cancer of Gastrointestinal Tract;   Cancer of the Gastrointestinal Tract;   Gastrointestinal Cancer;   Neoplasms, Gastrointestinal
Intervention:
16 Recruiting AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer
Conditions: Colonic Neoplasms;   Cancer of the Colon;   Colon Cancer;   Colon Neoplasms;   Colonic Cancer
Interventions: Drug: Cetuximab;   Drug: AZD6244
17 Recruiting Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: Anal Cancer;   Breast Cancer;   Esophageal Cancer;   Gastric Cancer;   Head and Neck Cancer;   Lung Cancer;   Nonneoplastic Condition;   Ovarian Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: vorinostat;   Other: laboratory biomarker analysis;   Other: pharmacological study
18 Recruiting Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Conditions: Urethral Neoplasms;   Neoplasms, Urethral;   Ureter Cancer;   Cancer of the Urethra;   Urethral Cancer
Interventions: Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Lenalidomide
19 Recruiting Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer;   Breast Tumors;   Cancer of Breast;   Cancer of the Breast;   Human Mammary Carcinoma;   Neoplasms, Breast
Interventions: Procedure: Remove tumor only;   Procedure: Removal of tumor and tissue
20 Recruiting Natural Killer Cells and Bortezomib to Treat Cancer
Conditions: Lung or Prostatic Neoplasms;   Colorectal or Kidney Neoplasms;   Pancreatic Neoplasms;   Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive;   Melanoma;   CLL
Intervention: Drug: NK cells +CliniMACs CD3 and CD56 systems

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services